Every woman should know her risk of breast cancer. There’s no one-size-fits-all approach to breast cancer screening anymore—each woman has a unique risk profile, and her screening path should reflect that.
She may need to start screening before the age of 40 because of a strong family history. Or she may require an MRI or other supplemental screening in addition to a mammogram because she has dense breasts.
This tool will help you guide her on her breast cancer screening journey.
The American Cancer Society and other leading organizations now recommend that women undergo a breast cancer risk assessment by the age of 25.
It’s the new standard of care in women’s health. Identifying those at high risk early allows for personalized care plans that include more frequent screenings, genetic counseling, and preventive measures.
With Luminary Risk Provider, you can seamlessly integrate the Tyrer-Cuzick, NCI, and BRCAPro risk models into your practice, ensuring that your patients receive the most accurate and comprehensive risk score. Unlike free online tools, our solution provides a comprehensive breast screening care plan for your patients and simple worklists to help you manage your high-risk patients.
Our easy-to-use platform allows patients to share their medical history from the comfort of their homes or in your office. This vital information helps assess their risk and craft a personalized care plan.
Luminary Risk Provider processes the collected patient history to produce a precise risk score. This clinically licensed tool ensures that you have a reliable basis for making informed decisions about your patient’s breast health.
Every patient receives a detailed care plan tailored to their risk level. High-risk patients may need supplemental screening beyond a mammogram or qualify for genetic counseling. This care plan helps you guide them through these recommendations.
Provide each patient with a detailed, tailored approach to managing their breast cancer risk. By considering individual risk factors—such as age, family history, and genetic predispositions—we create a care plan specifically designed for each patient’s unique risk level.
The care plan is based on recommendations from the NCCN and ACS ensuring that patients receive guidance that reflects the latest expert consensus.
Patients receive an easy-to-understand risk score, which helps them comprehend their lifetime risk of developing breast cancer compared to the average risk for women of the same age.
The care plan includes personalized screening recommendations, such as annual mammograms, ultrasound, breast MRI, and genetic counseling.
A mammogram alone may not be enough for many patients. This care plan helps clearly deliver information on how each patient should be screened for breast cancer based on her unique risk.
With over 30 years of experience in mammography and high-risk screening, MagView has become a trusted partner in breast cancer care. Our deep industry knowledge means you can count on Luminary Risk Provider to be both reliable and cutting-edge.
Luminary Risk Provider clearly flags high-risk patients and brings you powerful tools to track and manage those patients.
Empower your patients with the knowledge they need. We provide educational resources that help them understand their risk and the next steps in their care journey.
Luminary Risk Provider allows you to document extended time with the patient and medical decision-making to qualify for an elevated Evaluation and Management billing code for the patient encounter.
With our cloud-based solution, no heavy IT lifting is required. It’s super easy to set up, and our team is here to support you every step of the way so you can be up and running in no time.
Request a demo today and see how Luminary Risk Provider can seamlessly integrate into your practice, providing the clinically licensed risk assessments you need to empower your patients about their breast health.
Incorporating Luminary Risk Provider into your patient visits is a game-changer in the fight against breast cancer. Equip yourself with the latest, most reliable tools and knowledge to identify high-risk patients early and guide them toward a brighter, healthier future.
A different approach to breast cancer screening begins here.
UPCOMING WEBINAR: Navigating New Regulations in 2024: A Guide to Compliance for MQSA, NAPBC, and MOD
